RVL Pharmaceuticals Statistics
Total Valuation
RVLPQ has a market cap or net worth of $111. The enterprise value is $38.99 million.
Market Cap | 111 |
Enterprise Value | 38.99M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
RVLPQ has 99.37 million shares outstanding. The number of shares has increased by 18.89% in one year.
Shares Outstanding | 99.37M |
Shares Change (YoY) | +18.89% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.00 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.06 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38, with a Debt / Equity ratio of 3.56.
Current Ratio | 0.38 |
Quick Ratio | 0.31 |
Debt / Equity | 3.56 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.05 |
Financial Efficiency
Return on equity (ROE) is -155.20% and return on invested capital (ROIC) is -95.04%.
Return on Equity (ROE) | -155.20% |
Return on Assets (ROA) | -56.80% |
Return on Capital (ROIC) | -95.04% |
Revenue Per Employee | $295,352 |
Profits Per Employee | -$546,128 |
Employee Count | 125 |
Asset Turnover | 0.31 |
Inventory Turnover | 9.90 |
Taxes
Income Tax | -277,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.09 |
Relative Strength Index (RSI) | 40.09 |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RVLPQ had revenue of $36.92 million and -$68.27 million in losses. Loss per share was -$0.71.
Revenue | 36.92M |
Gross Profit | 27.59M |
Operating Income | -70.78M |
Pretax Income | -68.54M |
Net Income | -68.27M |
EBITDA | -59.64M |
EBIT | -60.03M |
Loss Per Share | -$0.71 |
Balance Sheet
The company has $19.16 million in cash and $58.15 million in debt, giving a net cash position of -$38.99 million or -$0.39 per share.
Cash & Cash Equivalents | 19.16M |
Total Debt | 58.15M |
Net Cash | -38.99M |
Net Cash Per Share | -$0.39 |
Equity / Book Value | 16.33M |
Book Value Per Share | 0.16 |
Working Capital | -42.64M |
Cash Flow
In the last 12 months, operating cash flow was -$44.41 million and capital expenditures -$2.13 million, giving a free cash flow of -$46.54 million.
Operating Cash Flow | -44.41M |
Capital Expenditures | -2.13M |
Free Cash Flow | -46.54M |
FCF Per Share | -$0.47 |
Margins
Gross margin is 74.73%, with operating and profit margins of -191.72% and -184.91%.
Gross Margin | 74.73% |
Operating Margin | -191.72% |
Pretax Margin | -185.66% |
Profit Margin | -184.91% |
EBITDA Margin | -161.55% |
EBIT Margin | -162.59% |
FCF Margin | -126.05% |
Dividends & Yields
RVLPQ does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.89% |
Shareholder Yield | -18.89% |
Earnings Yield | -61,500,900.90% |
FCF Yield | -41,923,423.42% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RVLPQ has an Altman Z-Score of -12.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -12.4 |
Piotroski F-Score | 3 |